ClearPoint Neuro, Inc. (CLPT) vs CapsoVision, Inc. (CV)
- ClearPoint Neuro, Inc. CLPT 9.07 −5.91%
- CapsoVision, Inc. CV 6.53 +1.24%
ClearPoint Neuro, Inc. and CapsoVision, Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $343.2M against $294.1M — 1.2× the size. ClearPoint Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; CapsoVision, Inc. trades at 2.1×. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 16.7%. ClearPoint Neuro, Inc. has the higher net margin (−81.8% vs −214.7%) and the higher return on invested capital (−61.3% vs −460.9%). Across the 17 metrics below, ClearPoint Neuro, Inc. leads on 11 and CapsoVision, Inc. on 6.
Valuation
Profitability
| Metric | CLPT | CV | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.61% | 50.88% | 56.01% |
| Operating margin | (73.42%) | (217.09%) | (15.03%) |
| Net margin | (81.76%) | (214.74%) | (20.40%) |
| Free cash flow margin | (74.01%) | (200.77%) | (7.24%) |
| Return on equity | (226.52%) | 47.42% | (15.32%) |
| Return on assets | (46.21%) | (212.19%) | (19.72%) |
| Return on invested capital | (61.31%) | (460.93%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack